glp-1 weight loss news weight-loss drugs are a hot health topic. Now, critics are debating whether the medications should be banned in sports for potentially being performance-enhancing drugs. https://fox5sandiego.com/news /critics-concerned-glp-1-drugs-may-give Louisiana's Best Virtual Weight Loss

Approval was granted for adult obesity in 2021 for individuals with a BMI of 30 kg/m or 27 kg/m with comorbidities

Additionally, some patients may possibly develop nutritional deficiencies particularly in protein, iron, or B vitaminsif their reduced food intake is not nutritionally balanced

Kidney Int 2022;102:97489

Mechanisms of action and therapeutic applications of GLP-1 and dual GIP/GLP-1 receptor agonists

Jeremy Klukan It wasnt until I started having foot problems that I realized how much high blood sugar levels were affecting my daily life

Lilly and Novo are leaders in the weight-loss drug market, which some analysts expect could bring in more than $150bn in revenue by the next decade